Ilan Tsarfaty Selected Research

Phosphotransferases (Kinase)

1/2014	MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells.
1/2012	Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.
8/2004	In search of drug treatment for genetic defects in the DNA damage response: the example of ataxia-telangiectasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ilan Tsarfaty Research Topics

Disease

14	Neoplasms (Cancer) 01/2023 - 01/2002
6	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2006
5	Breast Neoplasms (Breast Cancer) 01/2023 - 06/2008
1	Weight Loss (Weight Reduction) 01/2023
1	Colitis 01/2023
1	Inflammation (Inflammations) 01/2023
1	Insulin Resistance 01/2016
1	Obesity 01/2016
1	Cardiotoxicity 01/2015
1	Prostatic Neoplasms (Prostate Cancer) 01/2014
1	Colonic Neoplasms (Colon Cancer) 05/2008
1	Colorectal Neoplasms (Colorectal Cancer) 05/2008
1	Adenocarcinoma 09/2006
1	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2004
1	Genomic Instability 08/2004
1	Hypertrophy 08/2003
1	Pathologic Processes 08/2003

Drug/Important Bio-Agent (IBA)

5	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 12/2015 - 05/2006
3	Glucose (Dextrose)FDA LinkGeneric 11/2014 - 10/2013
3	Phosphotransferases (Kinase)IBA 01/2014 - 08/2004
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014 - 01/2002
2	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 01/2012
2	CytokinesIBA 01/2023 - 01/2023
2	LipidsIBA 01/2022 - 01/2016
2	methyl inosine monophosphate (MIMP)IBA 01/2016 - 09/2006
2	MicroRNAs (MicroRNA)IBA 12/2015 - 01/2014
2	Growth Factor ReceptorsIBA 01/2014 - 08/2003
2	LigandsIBA 01/2014 - 05/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2012 - 08/2003
1	Protein Isoforms (Isoforms)IBA 01/2023
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2023
1	Dextrans (Dextran)FDA Link 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	SodiumIBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2022
1	AntigensIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	PlasticsIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2016
1	3-O-Methylglucose (3 O Methylglucose)IBA 11/2014
1	farnesylthiosalicylic acidIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	IsotopesIBA 10/2013
1	Deoxyglucose (2 Deoxy D glucose)IBA 10/2013
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2013
1	Antineoplastic Agents (Antineoplastics)IBA 03/2013
1	AnthracyclinesIBA 03/2013
1	Complementary DNA (cDNA)IBA 06/2008
1	ParaffinIBA 06/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2008
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 05/2008
1	Carrier Proteins (Binding Protein)IBA 09/2006
1	DNA (Deoxyribonucleic Acid)IBA 08/2004
1	Nuclear Proteins (Protein, Nuclear)IBA 08/2004
1	salicylhydroxamic acid (SHAM)IBA 08/2003
1	Monoclonal AntibodiesIBA 08/2003

Therapy/Procedure

7	Therapeutics 01/2023 - 01/2002
2	Drug Therapy (Chemotherapy) 04/2020 - 01/2015
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022